STOCK TITAN

Notifications

Limited Time Offer! Get Platinum at the Gold price until January 31, 2026!

Sign up now and unlock all premium features at an incredible discount.

Read more on the Pricing page

News for SQL Stock

Atlantic International Corp. Acquires Lyneer Staffing Solutions SeqLL Defers Proposed Cash and Stock Distributions to Stockholders in Connection With Proposed Acquisition SeqLL Announces Cash and Stock Dividend Record Date SeqLL to Conduct 1-for-40 Reverse Stock Split SeqLL Inc. Enters into a Definitive Merger Agreement with Lyneer Staffing Solutions and Atlantic Acquisition Corp. SeqLL Provides First Quarter 2023 Financial Results SeqLL Announces Fourth Quarter and Year End 2022 Financial Results SeqLL Inc. Announces Closing of $1.8 Million Registered Direct Offering SeqLL Inc. Announces Pricing of $1.8 Million Registered Direct Offering SeqLL Announces CRADA with the FBI Brian Paras joins SeqLL as Chief Business Officer SeqLL Provides Third Quarter 2022 Financial Results UPDATE -- SeqLL Announces Peer-Reviewed Publication of Novel Single-Molecule Liquid Biopsy Method in Nature Biotechnology SeqLL Announces Peer-Reviewed Publication of Novel Single-Molecule Liquid Biopsy Method in Nature Biotechnology SeqLL to Present at the H.C. Wainwright 24th Annual Global Conference SeqLL Inc. Receives Nasdaq Notification Regarding Minimum Bid Requirements SeqLL’s Single-Molecule Nucleosome Imaging Method Published in Peer Reviewed Cell Reports Journal SeqLL Provides First Quarter 2022 Financial Results and a Corporate Update SeqLL Announces Fourth Quarter and Year End 2021 Financial Results and Provides a Corporate Update SeqLL to Participate in the 2022 Virtual Growth Conference Presented by Maxim Group LLC and hosted by M-Vest SeqLL Announces Formation of Scientific Advisory Board SeqLL Inc. Announces Closing of Underwriters’ Option to Purchase Additional Shares of Common Stock in Connection with its Initial Public Offering SeqLL Announces Publication of a New Blood-Based RNA Sequencing Method to Detect Coronary Artery Disease SeqLL Announces Publication of a New Single-Cell Epitranscriptomic Method Powered by SeqLL’s tSMS® Platform
Back to Sitemap